Who we are
The KEMRI–Wellcome Trust Research Programme is a partnership between the Kenya Medical Research Institute, the Wellcome Trust, and the University of Oxford. Established in 1989, the Programme conducts multidisciplinary research spanning molecular and cellular science, clinical research, epidemiology, population health, health systems, economics, and policy research. It is headquartered in Kilifi, with an additional research hub in Nairobi and a collaborative site at the Mbale Clinical Research Institute in eastern Uganda. KWTRP works through strong national, regional, and global partnerships to deliver high-quality, innovative science and develop health research capacity.
Our Anchors
The KWTRP strategic plan is anchored in three interlinked pillars: impact, sustainability, and culture. These pillars reflect our vision of a research institution that generates high-quality science translating into locally and internationally relevant and meaningful improvements in health and well-being, while operating on a financially, environmentally, and operationally sustainable foundation, and defined by an inclusive, empowering, and values-driven research culture.
Explore our strategy
Publications
- Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.Kimenyi, K. M. Morter, R. Nyabundi, D. Orindi, B. Mwikali, K. Mwai, K. et al.Lancet Microbe, (2026). :101375
- Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa.Zerebinski, J. Broumou, I. Kimenyi, K. M. Aklillu, E. Andrade, C. M. Babiker, H. et al.J Infect Dis, (2026).
- Functional Data Analysis of Wearable Devices Reveals Subtle Time-Varying Differences of Sleep Efficiency on 24-Hour Blood Pressure Dynamics in People With HIV.Venkatraman, S. Lee, M. H. Etyang, A. O. Cichowitz, C. Kisigo, G. Willkens, M. et al.Hypertension, (2026). 83:e27216
- Evaluation of Rotavirus Vaccine Effectiveness by Severity of Rotavirus Disease: Findings From the MNSSTER-V Project.Moran, M. C. Cates, J. Balachandran, N. Umana, J. Safi, H. Makhuza, H. et al.Pediatr Infect Dis J, (2026).
Policy Briefs
- Adopting the EEEC Framework to optimize critical provision in Kenya
- Final copy Summary of research findings by The CHAIN Network and KEMRI-Wellcome Trust
- Improving case detection of tuberculosis in hospitalised Kenyan children
- Using ‘Magnet Theatre’ to engage public audiences with health research in coastal Kenya


